Skip to main content

Advertisement

Table 1 Faecal microbiota composition of untreated and treated CD patients and age-matched healthy controls assessed by FISH and FCM

From: Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children

Microbial groups Specific group-probed cells/EUB-388 cells (%)1
  Untreated CD (n = 24) Treated CD (n = 18) Control (n = 20)
  Median Range Median Range Median Range
Bifidobacterium 7.73 22.08-3.27 9.20 33.82-1.58 12.54 33.68-6.94
C. histolyticum 5.26 27.61-0.71 9.41 39.60-2.95 11.61 35.69-0.16
C. lituseburense 3.23 27.24-0.17 4.41 29.85-0.28 6.83 19.56-1.05
Lactobacillus-Enterococcus 1.94 10.93-0.14 1.12 9.30-0.22 1.76 16.47-0.25
Staphylococcus 10.36 37.38-0.89 16.49 42.91-0.51 18.04 41.32-0.19
Bacteroides-Prevotella 3.54 20.85-0.80 2.61 15.07-0.25 2.32 5.53-0.33
E. coli 5.20 23.42-0.48 6.39 28.77-0.55 7.32 28.26-1.10
F. prausnitzii 6.03 37.50-1.07 11.09 37.84-2.95 13.88 37.08-2.32
Sulphate-reducing bacteria 9.58 38.02-2.84 9.82 41.74-2.09 10.02 36.92-2.92
  1. 1 Data were expressed as proportions of bacterial cells hybridising with group-specific probes to total bacteria hybridising with EUB probe 338.
  2. * Statistical significant differences were calculated using the Mann-Whitney U-test and established at P < 0.050.